Stay updated on JNJ-67856633 in NHL & CLL Clinical Trial
Sign up to get notified when there's something new on the JNJ-67856633 in NHL & CLL Clinical Trial page.

Latest updates to the JNJ-67856633 in NHL & CLL Clinical Trial page
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for the completed Phase 1 study of JNJ-67856633 in participants with NHL and CLL is now displayed, with study details, eligibility criteria, outcome measures, and locations.SummaryDifference60%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check21 days agoChange DetectedA sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to transition updates and FAQs.SummaryDifference1%

- Check27 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2. The page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check34 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedAccess to the study record has changed from a detailed page to a 403 Forbidden error page, with minimal navigation and a revision note, indicating the content is no longer publicly viewable. This replaces the full study details, locations, and related information that were previously visible.SummaryDifference17%

Stay in the know with updates to JNJ-67856633 in NHL & CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-67856633 in NHL & CLL Clinical Trial page.